Author:
Leis Hans J.,Windischhofer Werner
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Parsons CG, Danysz W, Quack G (1999) Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist—a review of preclinical data. Neuropharmacology 38(6):735–767
2. Jarvis B, Figgitt DP (2003) Memantine. Drugs Aging 20(6):465–476, discussion 477–468
3. Schneider E, Fischer PA, Clemens R, Balzereit F, Funfgeld EW, Haase HJ (1984) Effects of oral memantine administration on Parkinson symptoms. Results of a placebo-controlled multicenter study. Dtsch Med Wochenschr 109(25):987–990
4. Ditzler K (1991) Efficacy and tolerability of memantine in patients with dementia syndrome. A double-blind, placebo controlled trial. Arzneimittelforsch/Drug Res 41(8):773–780
5. Kornhuber J, Weller M, Schoppmeyer K, Riederer P (1994) Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties. J Neural Transm Suppl 43:91–104
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献